Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
Status: Enrolling
Updated:  11/9/2017
Investigational Site Number 4104
mi
from
Porto Alegre,
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
Status: Enrolling
Updated: 11/9/2017
Investigational Site Number 4104
mi
from
Porto Alegre,
Click here to add this to my saved trials
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
Status: Enrolling
Updated:  11/9/2017
Washington University
mi
from
Saint Louis, MO
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
Status: Enrolling
Updated: 11/9/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Treated With Antipsychotic Medication And Potential Effects on Cognitive Function
Status: Enrolling
Updated:  11/9/2017
Nathan Kline Institute for Psychiatric Research
mi
from
New York, NY
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Treated With Antipsychotic Medication And Potential Effects on Cognitive Function
Status: Enrolling
Updated: 11/9/2017
Nathan Kline Institute for Psychiatric Research
mi
from
New York, NY
Click here to add this to my saved trials
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated:  11/10/2017
The Coleman Center for Cosmetic and Dermatologic Surgery
mi
from
Metairie, LA
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated: 11/10/2017
The Coleman Center for Cosmetic and Dermatologic Surgery
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated:  11/10/2017
Maryland Laser, Skin and Vein Institute
mi
from
Hunt Valley, MD
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated: 11/10/2017
Maryland Laser, Skin and Vein Institute
mi
from
Hunt Valley, MD
Click here to add this to my saved trials
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated:  11/10/2017
SkinCare Physicians
mi
from
Chestnut Hill, MA
Study of the Cabochon System for Improvement in the Appearance of Cellulite
Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite
Status: Enrolling
Updated: 11/10/2017
SkinCare Physicians
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Medical Affliated Research Center, Inc.
mi
from
Huntsville, AL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Medical Affliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Precision Trials/Valley Urologic Associates
mi
from
Glendale, AZ
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Precision Trials/Valley Urologic Associates
mi
from
Glendale, AZ
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Premier Clinical Research Center
mi
from
Phoenix, AZ
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Premier Clinical Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Tower Urology / Tower Research Institute
mi
from
Los Angeles, CA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Tower Urology / Tower Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
San Diego Sexual Medicine
mi
from
San Diego, CA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
LABiomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Torrance, CA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
LABiomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Conneticut Clinical Research Center
mi
from
Middlebury, CT
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Conneticut Clinical Research Center
mi
from
Middlebury, CT
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
PAB Clinical Research
mi
from
Brandon, FL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Sunstone Medical Research, LLC
mi
from
Medford, OR
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Clinical Trial Network
mi
from
Houston, TX
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Potenium Clinical Research, LLC
mi
from
Hurst, TX
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Potenium Clinical Research, LLC
mi
from
Hurst, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Rainer Clinical Research Center, Inc.
mi
from
Renton, WA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Rainer Clinical Research Center, Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Precision Trials/Valley Urologic Associates
mi
from
Phoenix, AZ
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Precision Trials/Valley Urologic Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
South ORange County Endocrinology
mi
from
Laguna Hill, CA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
South ORange County Endocrinology
mi
from
Laguna Hill, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
South Florida Medical Research
mi
from
Aventura, FL
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
University Urology Associates
mi
from
New York, NY
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
University Urology Associates
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Unrologic Consultants of SE Pennsylvania
mi
from
Bala-Cynwyd, PA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Unrologic Consultants of SE Pennsylvania
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Research Across America
mi
from
Carrollton, TX
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Research Across America
mi
from
Carrollton, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Research Across America
mi
from
Dallas, TX
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated:  11/14/2017
Univ of Washington
mi
from
Seattle, WA
Safety and Efficacy Trial of Testosterone Undecanoate
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status: Enrolling
Updated: 11/14/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity
Status: Enrolling
Updated:  11/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity
Status: Enrolling
Updated: 11/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
AMCR Institute, Inc
mi
from
Escondido, CA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
AMCR Institute, Inc
mi
from
Escondido, CA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Palm Research Center
mi
from
Las Vegas, NV
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Palm Research Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Therapeutic Research Institute of Orange County
mi
from
Laguna Hills, CA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Therapeutic Research Institute of Orange County
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Stanford University
mi
from
Stanford, CA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Swedish Medical Center
mi
from
Seattle, WA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Princess Alexandra Hospital
mi
from
Woolloongabba,
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Princess Alexandra Hospital
mi
from
Woolloongabba,
Click here to add this to my saved trials
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  11/21/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 11/21/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
A Pilot Study Assessing the Use of Continuous Subcutaneous Hydrocortisone Infusion in the Treatment of Congenital Adrenal Hyperplasia
Status: Enrolling
Updated:  11/24/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
A Pilot Study Assessing the Use of Continuous Subcutaneous Hydrocortisone Infusion in the Treatment of Congenital Adrenal Hyperplasia
Status: Enrolling
Updated: 11/24/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery
Status: Enrolling
Updated:  11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery
Status: Enrolling
Updated: 11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients.
Status: Enrolling
Updated:  11/29/2017
Hospital for Special Surgery
mi
from
New York, NY
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients.
Status: Enrolling
Updated: 11/29/2017
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Brain Function in Depression and Insulin Resistance
Brain Function in Depression and Insulin Resistance
Status: Enrolling
Updated:  12/2/2017
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Brain Function in Depression and Insulin Resistance
Brain Function in Depression and Insulin Resistance
Status: Enrolling
Updated: 12/2/2017
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
Treatment of High Risk, Inherited Lysosomal and Peroxisomal Disorders by Reduced-Intensity Hematopoietic Cell Transplantation and Low-Dose Total Body Irradiation With Marrow Boosting by Volumetric-Modulated Arc Therapy (VMAT)
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
Treatment of High Risk, Inherited Lysosomal and Peroxisomal Disorders by Reduced-Intensity Hematopoietic Cell Transplantation and Low-Dose Total Body Irradiation With Marrow Boosting by Volumetric-Modulated Arc Therapy (VMAT)
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Stem Cell Transplant for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Stem Cell Transplant for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Stem Cell Transplantation for Hurler
Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Stem Cell Transplantation for Hurler
Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  12/3/2017
University of Minnesota - Fairview
mi
from
Minneapolis, MN
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 12/3/2017
University of Minnesota - Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials